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ABSTRACT
Althoughcancercanonoccasionbecausedbyinfectious
agentssuchasspecificbacteria,parasites,andviruses,it
is not generally considered a transmissible disease. In
rare circumstances, however, direct communication
from one host to another has been documented. The
Tasmanian devil is now threatened with extinction in
thewildbecauseofafataltransmissiblecancer,devilfa-
cial tumor disease (DFTD). Another example is canine
transmissible venereal tumor (CTVT or Sticker’s sar-
coma)indogs.Thereisavastdifferenceinprognosisbe-
tween these two conditions. DFTD is often fatal within 6
months, whereas most cases of CTVT are eventually re-
jectedbythehostdog,whothenisconferredlifelongim-
munity. In man, only scattered case reports exist about
such communicable cancers, most often in the setting of
organ or hematopoietic stem cell transplants and can-
cers arising during pregnancy that are transmitted to
the fetus. In about one third of cases, transplant recipi-
ents develop cancers from donor organs from individu-
als who were found to harbor malignancies after the
transplantation.Thefactthattwothirdsofthetimecan-
cer does not develop, along with the fact that cancer
very rarely is transmitted from person to person, sup-
ports the notion that natural immunity prevents such
cancers from taking hold in man. These observations
might hold invaluable clues to the immunobiology and
possible immunotherapy of cancer. The Oncologist 2011;
16:1–4
INTRODUCTION
Inthecancerclinic,physiciansandotheroncologycaregiv-
ers are occasionally asked whether cancer can ever be
passed along from one individual to another. One example
is the wife who asks whether she could ever “catch” cancer
from her husband with prostate cancer. Although the an-
swertothatoneisno,thequestionofaman“catching”can-
cer from a partner with cervical cancer is not unrealistic
since various strains of human papilloma virus are known
causes of cervical cancer as well as penile cancer. Patho-
gens including certain viruses, bacteria, and parasites rep-
resent major causes of cancer in developing parts of the
world. In fact, an estimated 1.5 million cases per year or
15%ofallcancersworldwidecanbeattributedtoinfectious
etiologies, mostly (11%) due to viral infections. Some
specific examples among DNA viruses include the follow-
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The Oncologist 2011;16:1–4 www.TheOncologist.coming: hepadnaviruses such as hepatitis B virus (hepatocellu-
lar carcinoma); herpesviruses such as Kaposi sarcoma–
associatedherpesvirus,alsoknownashumanherpesvirus-8
(Kaposisarcomaandprimaryeffusionlymphoma),andEp-
stein-Barr virus (nasopharyngeal carcinoma and non-
Hodgkin and Hodgkin lymphomas); polyomaviruses such
as Merkel cell virus (Merkel cell carcinoma) [1]; and spe-
cific human papilloma virus strains (anogenital cancers in
men and women and some head and neck cancers). Inter-
estingly, the specific human papilloma virus (HPV) strains
achieve their carcinogenicity through degradation or inac-
tivation of p53 and Rb via the products of their “early
genes” E6 and E7, respectively. This mechanism targeting
of the key proteins, p53 and Rb, is a common theme uncov-
ered during the early investigations of oncogenic DNA vi-
ruses such as the SV40 polyoma virus and certain
adenovirusesthatcausedcancersinanimals.Thus,earlyin-
vestigations of these DNA viral mechanisms were instru-
mental in the discovery of p53 [2, 3] and Rb [4, 5]
RNA viruses implicated in human cancers include fla-
viviruses such as hepatitis C virus, another known cause of
hepatocellular carcinoma and retroviruses such as human
T-lymphotropic virus 1 (HTLV-1), which causes adult T-
cell leukemia/lymphoma. Another retrovirus putatively as-
sociated with human cancers at the time of this writing is
HTLV-2,whichmaybelinkedtohairycellleukemia[6].A
retrovirus named HTLV-5 was reported to be associated
with cutaneous T-cell lymphoma (mycosis fungoides) over
2 decades ago but no further confirmatory data has arisen
[7]. Human immunodeficiency virus (HIV), as a cofactor,
has been associated with increased incidence of several
non-AIDSdefiningcancers,includingHodgkinlymphoma,
lung cancer, renal cell carcinoma, and hepatocellular carci-
noma among others [8].
Bacterial infections such as CagA-positive strains of
Helicobacter pylori are associated with gastric carcinomas
and MALT lymphomas. Chlamydia psittaci, the cause of
psittacosis, has been linked to ocular adnexal lymphomas
[9]. Borellia burgdorferi, the cause of Lyme disease, has
also been linked to primary cutaneous B-cell lymphomas
[10] and Campylobacter jejuni appears associated with im-
munoproliferativediseaseofthesmallintestine[11].Asfar
asparasitesgo,practicallyallmedicalstudentsareawareof
the link between squamous cell carcinoma of the bladder
and Schistosoma hematobium. Opisthorchis viverrini is
classifiedbytheInternationalAgencyforResearchonCan-
cer as a Group I Carcinogen for cholangiocarcinoma,
whereas Clonorchis sinensis was categorized as a probable
cause (Group 2A) [12].
These infectious causes of cancer are well studied and
investigations of virally caused cancers in animals have
contributed immensely to the understanding about the mo-
lecular biology of cancer. However, a very different and
less well-studied form of “contagious cancer” is currently
wreaking havoc in the natural world—and one wonders
whether a deeper understanding of these transmissible can-
cers might similarly prove fruitful in furthering the under-
standing of cancer biology and treatment.
The largest extant carnivorous marsupial, the Tasma-
niandevil,Sarcophiliusharrisii,couldpossiblybecomeex-
tinct in the wild because of a communicable cancer known
as devil facial tumor disease (DFTD). Since first being rec-
ognized in 1996, it is estimated that the wild population has
declined by about 50% and the Tasmanian devil has been
listed as endangered by the International Union for Conser-
vation of Nature. The cancer is spreading so rapidly that
some researchers fear there may be no disease-free Tasma-
nian devils left in the wild within 5 years and that the spe-
cies could become extinct within 20 years. The locally
aggressive malignancy often causes death within 6 months
because of consequences of airway obstruction and inabil-
itytofeed.DFTDisdirectlytransmittedduringfightingand
courtship battles in which facial tumor cells of one animal
are transferred to another as an allograft. Confirmation that
this same tumor has been passed along in this fashion for
over a decade now is provided by elegant cytogenetic stud-
ies that have documented identical aneuploidy in all tumor
samples (13 total chromosomes) in contrast to the 14 chro-
mosomes in normal host cells [13, 14]. A recent analysis
has indicated that DFTD is of Schwann cell origin [15].
In stark contrast to the fatal DFTD, another contagious
cancer, canine transmissible venereal tumor (CTVT), is
normallynotlethaltoitsdoghosts.AlsoknownasSticker’s
sarcoma, CTVT was initially described in 1876 and may
have originated in a wolf as long as 2,500 years ago. It has
been passed along among canines ever since, making it the
oldestrecognizedmalignantcellline[16,17].Thereissolid
evidencethatthistumorispassedonasanallograft,includ-
ing the fact that CTVT cells have a strikingly different
karyotypefromthehost’scells,yetaresimilartoeachother
even when the hosts are from different continents. The can-
cer is typically transmitted during mating when the malig-
nant tumor cells from one dog are directly transferred to
another dog via coitus, licking, biting, and sniffing tumor-
affected areas (the genitals, nose, or mouth). Although ca-
pable of metastasizing, CTVT often does not require
treatment, as spontaneous regression is the general rule.
Although customarily CTVT is ultimately rejected, it
has some fascinating properties that have allowed it to per-
sist and be transmitted for so many generations. First, it
downregulates its MHC I expression, thereby reducing its
initial visibility to the host’s immune system [17]. This
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lows it to not only escape T-cell–mediated immunity
(whichwouldoccurifMHCIwerefullyexpressed)butalso
natural killer cells (which would eradicate the cells were
theycompletelydevoidofMHCI).Inmostcases,thedog’s
immune system eventually reacts to the allograft and clears
it, rendering the dog immune to future challenges. The fact
thatimmunosuppresseddogscandevelopmetastaticCTVT
supports the concept of immune-mediated rejection in
healthy animals.
Thus, there is an interesting contrast between the lethal
DFTD of Tasmanian devils and the normally nonfatal
CTVT of dogs. It appears that Tasmanian devil populations
are lacking in genetic diversity and the transplanted tumors
cells are not rejected as they are in dogs, allowing disease
progression and a fatal outcome. In both cases the transmit-
ted cancer is essentially a somatic cell line that has become
atransmissibleparasite.SuchobservationshaveledMurgia
et al. [17] to speculate that one reason for MHC diversity in
vertebrates is precisely to ensure that cancer is not commu-
nicable.
Direct transmissions of cancers are not entirely re-
stricted to animals. There are approximately 3,500 women
per year in the United States who develop a malignancy
during pregnancy, and in rare cases, mother-to-fetus trans-
mission of melanoma, lymphoma, leukemias, and carcino-
mas have been reported as well as fetus-to-fetus
transmissionintwins.Althoughexceedinglyrare,0.04%of
organ transplant recipients contract cancer from the donor
organ (mostly melanomas) and hematologic malignancies
have been observed in about 0.06% of hematopoietic stem
cell transplants. Penn [18] observed that about one third of
recipients of organs from donors with some form of cancer
at the time of donation eventually developed the same ma-
lignancy as in the donor. Curiously, the remaining two
thirds did not show evidence of a transmitted cancer. Nat-
urally, this could be due to an absence of neoplastic cells in
the donated organ but alternatively it could be due to the
host’s rejection of foreign malignant clones. The latter con-
cept is bolstered by the fact that in cases in which cancer
does develop following transplantation of an organ from a
donor with cancer, the malignant process may regress after
the graft has been removed and immunosuppression dis-
continued [19–22]. Another report described a situation in
which a kidney and liver were transplanted from a donor
who was found to harbor pancreatic adenocarcinoma. The
liver recipient was re-transplanted shortly after the discov-
ery of the donor’s cancer whereas the kidney recipient
opted not to undergo removal of the transplanted organ; the
kidney recipient died with metastatic pancreatic adenocar-
cinoma 15 months after transplantation [23]. A slight vari-
ation of this scenario might be presented by the fact that
solidorgantransplantationcarriesa1outof200riskofKa-
posi sarcoma in the United States [24, 25]. In principle the
disease could originate directly from donated neoplastic
cells or as a result of reactivation of the Kaposi sarcoma–
associated herpesvirus (KSHV) carried along in the trans-
planted cells or as a result of immunosuppression that
allows KSHV to induce a de novo malignancy. Barrozi et
al. [25] showed that the KSHV-infected neoplastic cells
from transplant recipients with Kaposi sarcoma in 5 of 8
renal transplant patients harbored genetic or antigenic
markers of their matched donors, suggesting that they
were transplanted malignancies rather than KSHV-caused
Kaposi sarcomas that might have arisen due to immuno-
suppression. The authors even suggested the use of do-
nor-derived KSHV-specific T cells for the control of
post-transplant Kaposi sarcoma.
Other unusual reports of human-to-human transmis-
sions include colon cancer transmission via needle stick
[26], a volunteer with impaired health who developed me-
tastases from transferred allogeneic tumor cells [27], a case
of transplanted melanoma from a daughter to her elderly
mother [28], and a well-documented genetic analysis of a
case in which a surgeon contracted a malignant fibrous his-
tiocytoma from a patient following an intraoperative cut to
his left palm [29]. The surgeon had neither immunodefi-
ciency nor genetic relationship to the patient. The tumor,
which was successfully excised, proved to be a chimeric
constellation of alleles with some contributed by the tumor
and others from the surgeon host. Fortunately, survival of
transplanted cancers in healthy humans is exceedingly rare
and documented by only a small handful of cases. Thus,
friends and family members of cancer patients and we, as
caregiversofcancerpatients,neednotbeundulyconcerned
with the remote possibility of “catching cancer.”
As for the Tasmanian devils, researchers thought they
might have found an individual named Cedric who pos-
sessed immunity to DFTD and could be a savior for the
dwindling population. After initially inoculating Cedric
and his half-brother Clinky with irradiated tumor cells, fol-
lowed by injections with live tumor cells, Clinky rapidly
succumbed to the cancer. However, Cedric produced anti-
bodies and developed no tumors, prompting speculation
about the existence of resistant animals. Unfortunately, in a
follow-up study, Cedric was injected with a slightly differ-
ent strain of DFTD and wound up developing tumors—
dashing hopes of finding a resistant population. This was
naturally demoralizing news for conservationists but con-
firmed that there are different strains of the tumor and it
may be possible for an animal to be immune to one strain
but not others.
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immunity to CTVT in dogs are important for their pure sci-
entific interest. Similarly, the natural resistance humans
possess against transmitted malignancies (except under un-
usualcircumstancessuchasorgantransplantationfollowed
by chronic immunosuppression or immunosuppression
from other reasons) is of scientific interest. Together, the
observations might provide some critical clues that could
someday be of real practical value in advancing our battle
against cancer in the clinic.
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